1. Home
  2. BANL vs CLRB Comparison

BANL vs CLRB Comparison

Compare BANL & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

N/A

Current Price

$0.46

Market Cap

11.7M

Sector

Energy

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

N/A

Current Price

$2.76

Market Cap

12.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BANL
CLRB
Founded
2015
2002
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
12.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BANL
CLRB
Price
$0.46
$2.76
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
31.8K
43.7K
Earning Date
09-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$580,456,800.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.38
N/A
52 Week Low
$0.40
$2.71
52 Week High
$1.30
$20.60

Technical Indicators

Market Signals
Indicator
BANL
CLRB
Relative Strength Index (RSI) 49.07 32.90
Support Level $0.44 $3.30
Resistance Level $0.48 $3.15
Average True Range (ATR) 0.02 0.33
MACD 0.01 -0.05
Stochastic Oscillator 73.54 19.37

Price Performance

Historical Comparison
BANL
CLRB

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: